DUSP3 Antibody - Primary antibody, specific to DUSP3, Rabbit IgG

Features and benefits
  • Short Overview:

    pAb; Rabbit anti Human DUSP3 Antibody; WB, IHC, IF, ICC; Unconjugated

  • Species reactivity(Reacts with): Human,Mouse,Rat
  • Isotype: Rabbit IgG
    Application:
  • IF/ICC
  • IHC
  • WB
Item Number
Ab100596
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab100596-10μl
10μl
In stock
$66.90
Ab100596-50μl
50μl
In stock
$199.90
Ab100596-100μl
100μl
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$279.90
Ab100596-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,699.90

pAb; Rabbit anti Human DUSP3 Antibody; WB, IHC, IF, ICC; Unconjugated

Basic Description

Product NameDUSP3 Antibody - Primary antibody, specific to DUSP3, Rabbit IgG
Synonymsdual specificity phosphatase 3 | dual specificity protein phosphatase 3 | Dual specificity protein phosphatase VHR | DUSP3 | EC 3.1.3.16 | EC 3.1.3.48 | Vaccinia H1-related phosphatase | vaccinia virus phosphatase VH1-related | VHR | VHRserine/threonine s
Specifications & PurityExactAb™, Validated, 0.2 mg/mL
Host speciesRabbit
SpecificityDUSP3
ImmunogenA synthetic peptide derived from human DUSP3 (AA 1-17).
Positive ControlWB: HeLa, NIH/3T3, C6, Jurkat, MCF7, K562, HEK293, A431 and Hep G2 cell lysates. IHC: Human cholangiocarcinoma tissue. ICC/IF: HeLa cells.
ConjugationUnconjugated
GradeExactAb™, Validated
Product Description

Rabbit anti Human DUSP3 Antibody, Polyclonal, could be used for WB, IHC, IF, ICC and so on.
Application:
WB: 1/500-1/1000
IHC: 1/50-1/100
ICC/IF: 1/50-1/200
Protein function

Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines. Specifically dephosphorylates and inactivates ERK1 and ERK2.

Product Properties

IsotypeRabbit IgG
SDS-PAGE150 kDa
Purification MethodProtein A purified
FormLiquid
Concentration0.2 mg/mL
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle.

Images

DUSP3 Antibody (Ab100596) - Western Blot
All lanes: DUSP3 Antibody (Ab100596) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution

Predicted band size: 20 kDa
Observed band size: 20 kDa
Exposure time: 8.8 s

DUSP3 Antibody (Ab100596) - IF/ICC
Immunocytochemistry analysis of DUSP3 (green) in HeLa using DUSP3 Antibody (Ab100596), and cells were counterstained with DAPI (blue).


DUSP3 Antibody (Ab100596) - IHC
Immunohistochemistry analysis of paraffin-embedded Human Cholangiocarcinoma using DUSP3 Antibody (Ab100596). High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.

Associated Targets(Human)

DUSP3 Tchem Dual specificity protein phosphatase 3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DUSP3 Tchem Dual specificity protein phosphatase 3 (1161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Application

ApplicationDilution info
WB

1/500-1/1000

ICC/IF

1/50-1/200

IHC

1/50 - 1/100

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
ZJ24F0202749Certificate of AnalysisFeb 06, 2024 Ab100596
ZJ24F0202750Certificate of AnalysisFeb 06, 2024 Ab100596

Related Documents

References

1. He Y, Liu S, Menon A, Stanford S, Oppong E, Gunawan AM, Wu L, Wu DJ, Barrios AM, Bottini N et al..  (2013)  A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases..  J Med Chem,  56  (12): (4990-5008).  [PMID:23713581]
2. Yu X, Sun JP, He Y, Guo X, Liu S, Zhou B, Hudmon A, Zhang ZY.  (2007)  Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases..  Proc Natl Acad Sci USA,  104  (50): (19767-72).  [PMID:18056643]
3. Mak LH, Knott J, Scott KA, Scott C, Whyte GF, Ye Y, Mann DJ, Ces O, Stivers J, Woscholski R.  (2012)  Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases..  Bioorg Med Chem,  20  (14): (4371-6).  [PMID:22705189]
4. Katherine A Rawls,P Therese Lang,Jun Takeuchi,Shinichi Imamura,Tyler D Baguley,Christoph Grundner,Tom Alber,Jonathan A Ellman.  (2009-11-06)  Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA..  Bioorganic & medicinal chemistry letters,  19  ((24)): (6851-6854).  [PMID:19889539]
5. Lan Chen, Bo Zhou, Sheng Zhang, Li Wu, Yuehong Wang, Scott G Franzblau, Zhong-Yin Zhang,.  (2010-12-01)  Identification and characterization of novel inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis..  ACS medicinal chemistry letters,  ((7)): ( 355-359 ).  [PMID:21116447]
6. Malamas MS, Sredy J, Moxham C, Katz A, Xu W, McDevitt R, Adebayo FO, Sawicki DR, Seestaller L, Sullivan D, Taylor JR..  (2000)  Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties..  J Med Chem,  43  (7): (1293-1310).  [PMID:10753467]
7. Wu S, Vossius S, Rahmouni S, Miletic AV, Vang T, Vazquez-Rodriguez J, Cerignoli F, Arimura Y, Williams S, Hayes T, Moutschen M, Vasile S, Pellecchia M, Mustelin T, Tautz L..  (2009)  Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells..  J Med Chem,  52  (21): (6716-6723).  [PMID:19888758]
8. Zhang X, He Y, Liu S, Yu Z, Jiang ZX, Yang Z, Dong Y, Nabinger SC, Wu L, Gunawan AM, Wang L, Chan RJ, Zhang ZY..  (2010)  Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)..  J Med Chem,  53  (6): (2482-2493).  [PMID:20170098]
9. Molina G, Vogt A, Bakan A, Dai W, Queiroz de Oliveira P, Znosko W, Smithgall TE, Bahar I, Lazo JS, Day BW, Tsang M, Tsang M..  (2009)  Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages..  Nat Chem Biol,  (9): (680-687).  [PMID:19578332]
10. Bu Y, Shi T, Meng M, Kong G, Tian Y, Chen Q, Yao X, Feng G, Chen H, Lu Z..  (2011)  A novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2..  Bioorg Med Chem Lett,  21  (2): (874-878).  [PMID:21169016]
11. Bobkova EV, Liu WH, Colayco S, Rascon J, Vasile S, Gasior C, Critton DA, Chan X, Dahl R, Su Y, Sergienko E, Chung TD, Mustelin T, Page R, Tautz L..  (2011)  Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids..  ACS Med Chem Lett,  (2): (113-118).  [PMID:21503265]
12. Yu ZH, Chen L, Wu L, Liu S, Wang L, Zhang ZY..  (2011)  Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening..  Bioorg Med Chem Lett,  21  (14): (4238-4242).  [PMID:21669525]
13. He Y, Xu J, Yu ZH, Gunawan AM, Wu L, Wang L, Zhang ZY..  (2013)  Discovery and evaluation of novel inhibitors of mycobacterium protein tyrosine phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid scaffold..  J Med Chem,  56  (3): (832-842).  [PMID:23305444]
14. Li W, Li S, Higai K, Sasaki T, Asada Y, Ohshima S, Koike K..  (2013)  Evaluation of licorice flavonoids as protein tyrosine phosphatase 1B inhibitors..  Bioorg Med Chem Lett,  23  (21): (5836-5839).  [PMID:24047800]
15. Zeng LF, Zhang RY, Yu ZH, Li S, Wu L, Gunawan AM, Lane BS, Mali RS, Li X, Chan RJ, Kapur R, Wells CD, Zhang ZY..  (2014)  Therapeutic potential of targeting the oncogenic SHP2 phosphatase..  J Med Chem,  57  (15): (6594-6609).  [PMID:25003231]
16. Sasaki T, Li W, Higai K, Koike K..  (2015)  Canthinone alkaloids are novel protein tyrosine phosphatase 1B inhibitors..  Bioorg Med Chem Lett,  25  (9): (1979-1981).  [PMID:25819098]
17. He Y, Guo X, Yu ZH, Wu L, Gunawan AM, Zhang Y, Dixon JE, Zhang ZY..  (2015)  A potent and selective inhibitor for the UBLCP1 proteasome phosphatase..  Bioorg Med Chem,  23  (12): (2798-2809).  [PMID:25907364]
18. Tautz L, Senis YA, Oury C, Rahmouni S..  (2015)  Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy..  Bioorg Med Chem,  23  (12): (2786-2797).  [PMID:25921264]
19. He R, Bai Y, Yu ZH, Wu L, Gunawan AM, Zhang ZY..  (2014)  Diversity-Oriented Synthesis for Novel, Selective and Drug-like Inhibitors for a Phosphatase from Mycobacterium Tuberculosis..  Medchemcomm,  (10): (1496-1499).  [PMID:25505942]
20. Abdjul DB, Yamazaki H, Kanno SI, Wewengkang DS, Rotinsulu H, Sumilat DA, Ukai K, Kapojos MM, Namikoshi M..  (2017)  Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp..  Bioorg Med Chem Lett,  27  (5): (1159-1161).  [PMID:28189419]
21. Xie J, Si X, Gu S, Wang M, Shen J, Li H, Shen J, Li D, Fang Y, Liu C, Zhu J..  (2017)  Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment..  J Med Chem,  60  (24): (10205-10219).  [PMID:29155585]
22. Zhang J, Sasaki T, Li W, Nagata K, Higai K, Feng F, Wang J, Cheng M, Koike K..  (2018)  Identification of caffeoylquinic acid derivatives as natural protein tyrosine phosphatase 1B inhibitors from Artemisia princeps..  Bioorg Med Chem Lett,  28  (7): (1194-1197).  [PMID:29525218]
23. He R,Wang J,Yu ZH,Zhang RY,Liu S,Wu L,Zhang ZY.  (2016)  Inhibition of Low Molecular Weight Protein Tyrosine Phosphatase by an Induced-Fit Mechanism..  J Med Chem,  59  (19.0): (9094-9106).  [PMID:27676368]
24. Ishibashi, T T, Bottaro, D P DP, Chan, A A, Miki, T T and Aaronson, S A SA..  (1992)  Expression cloning of a human dual-specificity phosphatase..  Proceedings of the National Academy of Sciences of the United States of America,    (15):   [PMID:1281549]
25. Yuvaniyama, J J, Denu, J M JM, Dixon, J E JE and Saper, M A MA..  (1996)  Crystal structure of the dual specificity protein phosphatase VHR..  Science (New York, N.Y.),    (31):   [PMID:8650541]
26. Todd, J L JL, Tanner, K G KG and Denu, J M JM..  (1999)  Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway..  The Journal of biological chemistry,    (7):   [PMID:10224087]
27. Schumacher, Maria A MA, Todd, Jacob L JL, Rice, Adrian E AE, Tanner, Kirk G KG and Denu, John M JM..  (2002)  Structural basis for the recognition of a bisphosphorylated MAP kinase peptide by human VHR protein Phosphatase..  Biochemistry,    (5):   [PMID:11863439]
28. Zody, Michael C MC and 73 more authors..  (2006)  DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage..  Nature,    (20):   [PMID:16625196]
29. Thomas R Burkard,Melanie Planyavsky,Ines Kaupe,Florian P Breitwieser,Tilmann Bürckstümmer,Keiryn L Bennett,Giulio Superti-Furga,Jacques Colinge.  (2011-01-29)  Initial characterization of the human central proteome..  BMC systems biology,  (17-17).  [PMID:21269460]

Solution Calculators